Related Experiment Video
Updated: Feb 14, 2026

Quantification of Violacein in Chromobacterium violaceum and Its Inhibition by Bioactive Compounds
Published on: August 8, 2025
Identification of Key Bioactive Compounds of Medicine-Food Homologous Substances and Their Multi-Target Intervention
Jie Ren1, Xue Zhang1, Siyu Chen1
1School of Basic Medical Sciences, Jiamusi University, Jiamusi 154007, China.
Abstract:
Osteosarcoma (OS), a highly aggressive bone malignancy, is hard to treat due to complex molecular mechanisms. This study aimed to identify key bioactive compounds from medicine-food homologous (MFH) substances for OS intervention. We analyzed GEO transcriptomic data to get 317 differentially expressed genes (DEGs), screened bioactive compounds from 106 MFH via dual databases, predicted compound-DEG protein interactions with GraphBAN, and filtered 11 core compounds through drug-likeness/toxicity evaluations. Regulatory networks identified 5 key target genes (SOST, ACACB, TACR1, GRIN2B, MPO), 10 key compounds (e.g., ellagic acid dihydrate) and 8 MFHs (e.g., Daidaihua). Molecular docking/MD confirmed stable complexes. GSEA/GSVA revealed pathway dysregulation (e.g., upregulated WNT signaling), and immune analysis showed altered infiltration of 5 cell subsets. 143B cell experiments and qRT-PCR validated findings. MFH-derived compounds, especially ellagic acid dihydrate, have multi-target anti-OS potential, laying a foundation for novel OS therapeutics.
Insights
This study identified potent bioactive compounds from medicine-food homologous substances as potential treatments for osteosarcoma (OS). Ellagic acid dihydrate shows promise for multi-target intervention against this aggressive bone cancer.
Area of Science:
- Oncology
- Pharmacology
- Bioinformatics
Background:
- Osteosarcoma (OS) is a complex bone cancer with limited treatment options.
- Identifying novel therapeutic targets and compounds is crucial for OS intervention.
Purpose of the Study:
- To identify key bioactive compounds from medicine-food homologous (MFH) substances for osteosarcoma treatment.
- To explore the molecular mechanisms and therapeutic potential of MFH-derived compounds against OS.
Main Methods:
- Analysis of GEO transcriptomic data to identify differentially expressed genes (DEGs) in OS.
- Screening of bioactive compounds from 106 MFH substances and prediction of compound-DEG protein interactions.
- Molecular docking, molecular dynamics (MD), Gene Set Enrichment Analysis (GSEA), and Gene Set Variation Analysis (GSVA) for validation.
Main Results:
- Identified 317 DEGs, 11 core bioactive compounds, and 8 key MFHs.
- Ellagic acid dihydrate and Daidaihua emerged as promising candidates.
- Confirmed stable compound-target interactions and identified dysregulated pathways like WNT signaling.
Conclusions:
- Medicine-food homologous (MFH)-derived compounds, particularly ellagic acid dihydrate, exhibit multi-target potential against osteosarcoma.
- These findings provide a foundation for developing novel therapeutic strategies for OS.
More Related Videos
09:24Standardized Identification of Compound Structure in Tibetan Medicine Using Ion Trap Mass Spectrometry and Multiple-Stage Fragmentation Analysis
Published on: March 17, 2023
03:11Author Spotlight: Standardized Herbal Decoction Protocol for Enhanced Animal Studies
Published on: June 7, 2024
Related Concept Videos
Homologous Recombination
Homologous Recombination
Key Elements for Plant Nutrition
Pharmacogenomics: Identification of New Drug Targets
Solubility of Ionic Compounds
Classification of Elements and Compounds
Compounds are pure substances composed of two or more elements in fixed, definite proportions. Compounds are classified as ionic or molecular (covalent) based on the bonds...